Cargando…

On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations

INTRODUCTION: Magnetic Resonance-guided Radiation Therapy (MRgRT) allows online adaptations (OA) of the treatment plan to optimize daily dose distribution based on patient's anatomy, just before fraction delivery. The aim of this study is to evaluate feasibility and the dosimetric improvement o...

Descripción completa

Detalles Bibliográficos
Autores principales: Placidi, Lorenzo, Romano, Angela, Chiloiro, Giuditta, Cusumano, Davide, Boldrini, Luca, Cellini, Francesco, Mattiucci, Gian Carlo, Valentini, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334416/
https://www.ncbi.nlm.nih.gov/pubmed/32642565
http://dx.doi.org/10.1016/j.tipsro.2020.06.001
_version_ 1783553929659809792
author Placidi, Lorenzo
Romano, Angela
Chiloiro, Giuditta
Cusumano, Davide
Boldrini, Luca
Cellini, Francesco
Mattiucci, Gian Carlo
Valentini, Vincenzo
author_facet Placidi, Lorenzo
Romano, Angela
Chiloiro, Giuditta
Cusumano, Davide
Boldrini, Luca
Cellini, Francesco
Mattiucci, Gian Carlo
Valentini, Vincenzo
author_sort Placidi, Lorenzo
collection PubMed
description INTRODUCTION: Magnetic Resonance-guided Radiation Therapy (MRgRT) allows online adaptations (OA) of the treatment plan to optimize daily dose distribution based on patient's anatomy, just before fraction delivery. The aim of this study is to evaluate feasibility and the dosimetric improvement of the OA workflow implemented in our institution for locally advanced pancreatic cancer (LAPC) patients, in terms of target coverage and organs at risk (OARs) sparing. METHODS: We retrospectively analysed 8 LAPC patients treated with MRgRT in combination with the OA approach, using video-assisted inspiratory breath-hold for a total of 38 fractions with a dose ranging from 30 Gy to 40 Gy in 5 fractions. Dose distribution of the baseline plan was first calculated based on daily anatomy, obtaining a “predicted” plan to assess the dosimetric improvement. If the dose distribution did not meet the constraints set in the planning phase, PTV, GTV and OARs were re-contoured within a distance of 3 cm from the PTV external edge and a new online “adaptive” plan was generated. Other clinical and planning parameters were also evaluated to assess the feasibility and the dosimetic benefit of the online adaptive workflow. RESULTS: Out of 38 total fractions, 26 (68.4%) were adapted online and 12 (31.6%) were delivered using the baseline plan. The use of the adaptive workflow resulted to be feasible in our clinical practice and advantageous in all the patients: mean PTV V95% increased by 10.8% (5.7–20.8) while mean CTV V98% of 12.6% (7.3–17.7). Also OARs V33 and V25 showed a positive trend avoiding unnecessary irradiation. CONCLUSION: OA workflow improves the dosimetric benefit of MRgRT, preventing the occurrence of high-doses to OARs and increasing the safety of stereotactic treatment for LAPC, without any drawback for our daily clinical practice routine.
format Online
Article
Text
id pubmed-7334416
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73344162020-07-07 On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations Placidi, Lorenzo Romano, Angela Chiloiro, Giuditta Cusumano, Davide Boldrini, Luca Cellini, Francesco Mattiucci, Gian Carlo Valentini, Vincenzo Tech Innov Patient Support Radiat Oncol Research article INTRODUCTION: Magnetic Resonance-guided Radiation Therapy (MRgRT) allows online adaptations (OA) of the treatment plan to optimize daily dose distribution based on patient's anatomy, just before fraction delivery. The aim of this study is to evaluate feasibility and the dosimetric improvement of the OA workflow implemented in our institution for locally advanced pancreatic cancer (LAPC) patients, in terms of target coverage and organs at risk (OARs) sparing. METHODS: We retrospectively analysed 8 LAPC patients treated with MRgRT in combination with the OA approach, using video-assisted inspiratory breath-hold for a total of 38 fractions with a dose ranging from 30 Gy to 40 Gy in 5 fractions. Dose distribution of the baseline plan was first calculated based on daily anatomy, obtaining a “predicted” plan to assess the dosimetric improvement. If the dose distribution did not meet the constraints set in the planning phase, PTV, GTV and OARs were re-contoured within a distance of 3 cm from the PTV external edge and a new online “adaptive” plan was generated. Other clinical and planning parameters were also evaluated to assess the feasibility and the dosimetic benefit of the online adaptive workflow. RESULTS: Out of 38 total fractions, 26 (68.4%) were adapted online and 12 (31.6%) were delivered using the baseline plan. The use of the adaptive workflow resulted to be feasible in our clinical practice and advantageous in all the patients: mean PTV V95% increased by 10.8% (5.7–20.8) while mean CTV V98% of 12.6% (7.3–17.7). Also OARs V33 and V25 showed a positive trend avoiding unnecessary irradiation. CONCLUSION: OA workflow improves the dosimetric benefit of MRgRT, preventing the occurrence of high-doses to OARs and increasing the safety of stereotactic treatment for LAPC, without any drawback for our daily clinical practice routine. Elsevier 2020-07-02 /pmc/articles/PMC7334416/ /pubmed/32642565 http://dx.doi.org/10.1016/j.tipsro.2020.06.001 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research article
Placidi, Lorenzo
Romano, Angela
Chiloiro, Giuditta
Cusumano, Davide
Boldrini, Luca
Cellini, Francesco
Mattiucci, Gian Carlo
Valentini, Vincenzo
On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title_full On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title_fullStr On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title_full_unstemmed On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title_short On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations
title_sort on-line adaptive mr guided radiotherapy for locally advanced pancreatic cancer: clinical and dosimetric considerations
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334416/
https://www.ncbi.nlm.nih.gov/pubmed/32642565
http://dx.doi.org/10.1016/j.tipsro.2020.06.001
work_keys_str_mv AT placidilorenzo onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT romanoangela onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT chiloirogiuditta onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT cusumanodavide onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT boldriniluca onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT cellinifrancesco onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT mattiuccigiancarlo onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations
AT valentinivincenzo onlineadaptivemrguidedradiotherapyforlocallyadvancedpancreaticcancerclinicalanddosimetricconsiderations